Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP-TRIAL: Safety of Not Flushing Non-used PORT-A-CATH in Cancer Patients
NCT02492477Phase 1Terminated
- Sponsor
- Ordensklinikum Linz Barmherzige Schwestern
- Start
- Jan 2016
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Ordensklinikum Linz Barmherzige Schwestern. Primary endpoint: Incidences of PORT-A-CATH related events (persistent malfunction, thrombosis, infection) at 12 months. Started Jan 2016; status: terminated.
Beyond the preview
Go deeper on NCT02492477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492477.